Redeye updates its estimates for Ependion following the Q2 2024 report, which showed stronger sales but lower profitability. The near-term outlook remains uncertain, but the company is well-positioned for medium- to long-term success as the underlying markets recover. Ependion continues to invest significantly in new product development and strategic areas, while simultaneously maintaining good cost control.